Ad
related to: oppenheimer (film)
Search results
Netflix CEO's bonkers Barbie, Oppenheimer claim
ClutchPoints· 7 days agoThe Barbie–Oppenheimer phenomenon, widely known as “Barbenheimer,” took the pop culture world by storm in 2023. The two films were box office hits and...
Oppenheimer bullish on DraftKings stock, citing potential consolidation benefits By Investing.com
Investing.com· 7 days agoOn Tuesday, Oppenheimer analysts maintained their positive stance on DraftKings (NASDAQ:DKNG) stock,...
Oppenheimer maintains 'Outperform' on CATX with $2 target By Investing.com
Investing.com· 4 days agoOn Thursday, Oppenheimer reiterated an Outperform rating on Perspective Therapeutics Inc (NYSE:CATX)...
How soccer helped Lombard improve at baseball
Major League Baseball· 7 hours agoThis story was excerpted from Bryan Hoch’s Yankees Beat newsletter. To read the full newsletter, click here. And subscribe to get it regularly in your...
Christopher Nolan’s next film after Oppenheimer teased
The Independent US via AOL· 6 days agoChristopher Nolan is already preparing for his next project, his wife and longtime collaborator Emma...
...School’s Vice Dean Akira Mizuta Lippit On Reaction To ‘Oppenheimer’ In Japan & How Release...
Deadline via Yahoo News· 5 days agoEditor’s note: When Christopher Nolan’s eventual Best Picture Oscar winner Oppenheimer began its...
Oppenheimer gives an Outperform recommendation for Cyclacel Pharmaceuticals Inc
Knox Daily· 20 hours agoIn a filing, Cyclacel Pharmaceuticals Inc revealed its President and CEO Rombotis Spiro George acquired Company’s shares for reported $20122.0 on Dec 21 ’23. In the deal valued at $3.31 per ...
Oppenheimer's Stoltzfus Says S&P Could Top 5,500 by Year-End
Bloomberg· 4 days agoOppenheimer's John Stoltzfus says the S&P 500 could top 5,500 by the end of the year. He says...
Addiction to Blockbuster Franchises Is Killing Hollywood
The Nation· 12 hours agoTraditionally, Memorial Day is the start of Hollywood’s money-making period, the summer season when...
Oppenheimer Reaffirms “Outperform” Rating for Zscaler (NASDAQ:ZS)
ETF DAILY NEWS· 2 days agoZscaler (NASDAQ:ZS – Get Free Report)‘s stock had its “outperform” rating restated by Oppenheimer in a report released on Friday, Benzinga reports. Oppenheimer< ...
